Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis

29 Oct 2014

Abstract excerpt

OBJECTIVES: Syndecan-1 (SDC1), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and interleukin-6 (IL6) are expressed by malignant plasma cells and cells in the bone marrow microenvironment and may be involved in the angiogenic process in multiple myeloma (MM). METHODS: In this study, we examined the association between bone marrow angiogenesis estimated as micro-vessel density (MVD) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Multiple Myeloma Research and Treatments
Share to Proteoglycans and glycosaminoglycans research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25353275
DOI: 10.1111/ejh.12473

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesisPMID 25353275Read ↗

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug ResistanceSemantic proximity Read ↗

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activitySemantic proximity Read ↗

Construction and validation of a prognostic model of angiogenesis-related genes in multiple myelomaSemantic proximity Read ↗

Correlation analysis of circulating myeloma cells with tumor load, angiogenesis and disease progression of multiple myeloma and clinical significanceSemantic proximity Read ↗

Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple MyelomaSemantic proximity Read ↗

Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.Semantic proximity Read ↗

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma.Semantic proximity Read ↗

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.Semantic proximity Read ↗

JunB is a key regulator of multiple myeloma bone marrow angiogenesisSemantic proximity Read ↗

Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple MyelomaSemantic proximity Read ↗

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factorSemantic proximity Read ↗

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone lossSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.